semaglutide aki Comparative Renal Safety of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (FAERS)—Disproportionality Study ozempic #ozempic® #semaglutide #ozempicsideeffects #medicine

Is GLP-1 microdosing safe

Arzneimittelforschung 1991;41:1294-8

One example is retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, which demonstrated statistically significant weight loss (22.8-24.2%) and metabolic improvements in systolic and diastolic blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, and lipids in a 48-week phase 2 trial, highlighting its potential for future obesity management

MHT is a member of the scientific advisory board of ERX Pharmaceuticals, Cambridge, Mass

Heres how it helps: Reduces Appetite Because semaglutide slows down how quickly the stomach empties, it can make people feel full sooner and for a longer period after eating

FDA New Drug Application (NDA) requires extremely high financial and time commitments